insights_auto
Pse është ulur ANW 10,26%?
Zhytu më thellëchevron_right
ANW:FRA
Immuron Ltd
0,018 €
arrow_downward
-10,26%(-0,0020) 1D
14 tet, 10:00:00 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ANW...
Hap
0,02 €
I lartë
0,02 €
I ulët
0,02 €
Kapitalizimi i tregut
9,35 mln
Vëllimi mesatar
904,00
Vëllimi
0,00
Maksimumi 52-javor
0,04 €
Minimumi 52-javor
0,01 €
Numri i punonjësve
8
Hap
0,02 €
I lartë
0,02 €
I ulët
0,02 €
Kapitalizimi i tregut
9,35 mln
Vëllimi mesatar
904,00
Vëllimi
0,00
Maksimumi 52-javor
0,04 €
Minimumi 52-javor
0,01 €
Numri i punonjësve
8
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Stock Titan
·
1 ditë më parë
A travel-diarrhea pill showed 50% less severe diarrhea, but missed its main trial goals
TipRanks
·
1 ditë më parë
Immuron advances Travelan after Phase 2 data published in Nature journal
Profili
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Rreth Immuron Ltd
Drejtori ekzekutiv-
Punonjësit8
Themeluar më1994
SeliaBlackburn North, Victoria, Australi
Sektori-
Uebsajtiimmuron.com.au